Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songyue Liu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Preventive Cardiology|November 23, 2022
Global burden of disease attributable to high systolic blood pressure in older adults, 1990-2019: an analysis for the Global Burden of Disease Study 2019Yuxian Huang, Lingrui Meng, Canru Liu, et al.
Journal of Advanced Research|October 1, 2025
Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trialGuozhe Sun, Ning Ye, Chang Wang, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
Nature Medicine|April 21, 2025
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trialJiang He, Chuansheng Zhao, Shanshan Zhong, et al.
Journal of the American Heart Association|March 13, 2025
Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical TrialGuozhe Sun, Xiaofan Guo, Guangxiao Li, et al.
JAMA Cardiology|June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical TrialXiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine|June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control projectGuozhe Sun, Chang Wang, Ning Ye, et al.
China CDC Weekly|July 7, 2025
Hypertension Control in China: Translation from Clinical Trial to Real-World Application - Preliminary OutcomesGuozhe Sun, Hao Peng, Songyue Liu, et al.
Lancet (London, England)|March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trialJiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
BMC Medicine|March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trialSongyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Preventive Cardiology|November 23, 2022
Global burden of disease attributable to high systolic blood pressure in older adults, 1990-2019: an analysis for the Global Burden of Disease Study 2019Yuxian Huang, Lingrui Meng, Canru Liu, et al.
Journal of Advanced Research|October 1, 2025
Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trialGuozhe Sun, Ning Ye, Chang Wang, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
Nature Medicine|April 21, 2025
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trialJiang He, Chuansheng Zhao, Shanshan Zhong, et al.
Journal of the American Heart Association|March 13, 2025
Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical TrialGuozhe Sun, Xiaofan Guo, Guangxiao Li, et al.
JAMA Cardiology|June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical TrialXiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine|June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control projectGuozhe Sun, Chang Wang, Ning Ye, et al.
China CDC Weekly|July 7, 2025
Hypertension Control in China: Translation from Clinical Trial to Real-World Application - Preliminary OutcomesGuozhe Sun, Hao Peng, Songyue Liu, et al.
Lancet (London, England)|March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trialJiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
BMC Medicine|March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trialSongyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Pageof 3